GOOD NEWS The Deadline to Nominate for SICA'26 Social Impact Awards has been Extended to 25 August 2026! Register Now
SICA 2026 Article Top

India's Flagship CSR and Sustainability Summit. Register today to secure your seat.

Nomination Deadline Countdown
00Days
:
00Hrs
:
00Mins
:
00Secs
Register Delegate
Spin Wheel for Extra Discount!
3 min read

Lupin Debuts in Dow Jones Best-in-Class Indices 2026

Share This Story
csr

Representational image

Mumbai, May 19, 2026: Lupin Limited has been included for the first time in the Dow Jones Best-in-Class (DJBIC) Indices 2026, reflecting the company’s performance in environmental, social and governance (ESG) practices.

The pharmaceutical company has been listed in both the DJBIC World Index and the DJBIC Emerging Markets Index. The indices recognise companies demonstrating strong sustainability performance based on the S&P Global Corporate Sustainability Assessment (CSA).

According to the company, the DJBIC World Index tracks top-performing companies globally on ESG parameters, while the DJBIC Emerging Markets Index highlights sustainability leaders from emerging economies.

SICA 2026 Article Middle

Connect with 300+ corporates, foundations and social enterprise leaders.

Nomination Deadline Countdown
00Days
:
00Hrs
:
00Mins
:
00Secs

Lupin stated that it had earlier ranked among the top 1% globally in the S&P Global Corporate Sustainability Assessment 2025 with a score of 91 out of 100.

The company said its inclusion in the indices strengthens its positioning among global firms recognised for sustainability-led business practices and reinforces investor confidence in its governance and operational standards.

Ramesh Swaminathan, Executive Director, Global CFO, Head of IT and API Plus SBU, Lupin said, “Lupin’s inclusion in the Dow Jones Best-in-Class Indices reflects the strength of our governance framework and financial discipline and marks a meaningful advancement in our sustainability journey. This recognition reinforces our long-term value creation agenda—anchored in responsible growth, resilient performance, and our continued commitment to delivering affordable, high-quality medicines to patients worldwide.”

The company added that it will continue focusing on science-based sustainability targets, environmental stewardship, quality and safety standards, inclusive workplace practices and responsible supply chain management.

Start Your Journey with BigDisha

Top Stories

Featured

SICA 2026 Article Bottom

Explore sponsorship, branding and delegate alignment options for SICA 2026.

Nomination Deadline Countdown
00Days
:
00Hrs
:
00Mins
:
00Secs
Partner With Us
Spin Wheel for Extra Discount!
👋 Welcome! Have a question about SICA 2026 or TheCSRUniverse? Let's chat.
Taking longer than usual. Your connection may be slow or unstable.